Leksell GammaPlan 11.1 Product Usage: Leksell GammaPlan is a computer-based system designed f...
FDA Device Recall #Z-1412-2019 — Class II — June 27, 2018
Recall Summary
| Recall Number | Z-1412-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 27, 2018 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Elekta Instrument AB |
| Location | Stockholm, N/A |
| Product Type | Devices |
| Quantity | 52 devices |
Product Description
Leksell GammaPlan 11.1 Product Usage: Leksell GammaPlan is a computer-based system designed for Leksell Gamma Knife treatment planning.
Reason for Recall
The margin tool in Leksell GammaPlan 11.1 systematically overestimates margin in certain areas of the volume.
Distribution Pattern
Worldwide Distribution - US Nationwide distribution to GA, MD, NJ, PA, PR, WA. International distribution to Australia, Belgium, France, Germany, Hong Kong, Italy, Japan, Korea, Democratic People's Republic of, Netherlands, Romania, Russian Federation, Spain, Turkey, United Kingdom.
Lot / Code Information
Software Version 11.1
Other Recalls from Elekta Instrument AB
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0227-2025 | Class I | Elekta Disposable Biopsy Needle Kit for Leksell... | Sep 25, 2024 |
| Z-1397-2024 | Class I | Elekta Disposable Biopsy Needle Kit for Leksell... | Mar 15, 2024 |
| Z-1309-2023 | Class II | Instructions for Use for the following Leksell ... | Mar 1, 2023 |
| Z-2442-2020 | Class II | Leksell Vantage Stereotactic System, UDI/GTIN 7... | Jun 10, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.